SEC Form 4 · accession 0001140361-17-046520
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter C Farrell
Director
Period of report
Dec 14, 2017
Accepted (ET)
Dec 18, 2017 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF4 | Dec 14, 2017 | G | 23,689 | $84.43 | D | 269,296 | D | |
| ResMed Common StockF4 | Dec 14, 2017 | G | 23,689 | $84.43 | D | 245,607 | D | |
| ResMed Common StockF4 | Dec 15, 2017 | G | 1,180 | $84.97 | D | 244,427 | D | |
| ResMed Common StockF4 | Dec 18, 2017 | G | 3,351 | $86.00 | D | 240,896 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a gift of shares to the Farrell Family Foundation. Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares.
- F2Represents a gift of shares to the Greater Houston Community Foundation. Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares.
- F3Represents a gift of shares to Project Veritas. Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares.
- F4The price reported above represents the average of the high and low trading price on the day of the transaction.